K. Peony Yu
2019
In 2019, K. Peony Yu earned a total compensation of $5.9M as Chief Medical Officer at FibroGen, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $316,830 |
|---|---|
| Option Awards | $1,886,018 |
| Salary | $590,000 |
| Stock Awards | $3,044,223 |
| Other | $19,380 |
| Total | $5,856,451 |
Yu received $3M in stock awards, accounting for 52% of the total pay in 2019.
Yu also received $316.8K in non-equity incentive plan, $1.9M in option awards, $590K in salary and $19.4K in other compensation.
Rankings
In 2019, K. Peony Yu's compensation ranked 1,777th out of 13,971 executives tracked by ExecPay. In other words, Yu earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,777 out of 13,971 | 87th |
Division Manufacturing | 634 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 192 out of 2,200 | 91st |
Industry group Drugs | 154 out of 1,886 | 92nd |
Industry Pharmaceutical Preparations | 115 out of 1,398 | 92nd |
Source: SEC filing on April 23, 2020.
Yu's colleagues
We found five more compensation records of executives who worked with K. Peony Yu at FibroGen in 2019.
2019
Thomas Neff
FibroGen
Chief Executive Officer
2019
James Schoeneck
FibroGen
Chief Executive Officer
2019
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2019
Christine Chung
FibroGen
Senior Vice President, China Operations
2019
Pat Cotroneo
FibroGen